Remarkably, the NCSC-like cellular state in BRAF-mutated melanoma has also been associated with the development of non-genetic resistance to MAPK-targeted therapies in a NGFR/FAK/AKT-dependent manner [35, 36]. This evidence concerns the gene BRAF and melanoma.